CDC Loses 25%-30% of Staff as 80% of Senior Posts Stay Unfilled
Updated
Updated · The Guardian · Jul 22
CDC Loses 25%-30% of Staff as 80% of Senior Posts Stay Unfilled
3 articles · Updated · The Guardian · Jul 22
Summary
Former CDC leaders say the US is less prepared for the next pandemic than before Covid after the agency lost 25%-30% of its workforce and left about 80% of senior leadership jobs without permanent appointees.
A $40 million hit tied to the dismantling of USAID gutted parasite programs, cutting 35 of 73 employees, while the cyclospora lab shrank from 11 staff to three and expertise in Ebola, mpox and rabies also thinned.
Those losses are colliding with active threats including measles, hantavirus, Ebola and cyclospora, and officials say conflicting federal directives are making responses harder for states to execute.
More than half of US states have already limited public-health emergency powers, and former officials warn rebuilding specialized CDC capacity will take years even if funding returns.
With America's disease defense system dismantled, are we now defenseless against the next pandemic?
As US health surveillance abroad vanishes, what new global outbreaks are heading for American shores?
Can local alliances rebuild America's health safety net after the federal system's collapse?
CDC in Crisis: 2026 Staffing Collapse, Political Interference, and the Erosion of US Public Health Security
Overview
As of mid-2026, the CDC faces an unprecedented workforce crisis, with continued staff losses threatening its ability to protect public health. This crisis is rooted in deliberate political interventions and administrative restructurings, first initiated by the Trump administration and further advanced by HHS Secretary Robert F. Kennedy Jr. After President-elect Trump returned to office and appointed Kennedy Jr. to lead HHS, these changes accelerated, resulting in persistent attrition and instability. The ongoing loss of personnel poses a serious challenge to the CDC’s operational capacity, undermining its effectiveness and stability at a critical time for public health.